|
|
| Line 10: |
Line 10: |
|
| |
|
| {{CMG}} | | {{CMG}} |
|
| |
| ==Treatment==
| |
| Treatment usually involves:
| |
|
| |
| *[[Surgery]], to remove the tumor and a safety margin of healthy tissue. This is the mainstay of synovial sarcoma treatment and is curative in approximately 20-70% of patients, depending on the particular study being quoted.
| |
| *Conventional [[chemotherapy]], (for example, [[Doxorubicin hydrochloride]] and [[Ifosfamide]]), to reduce the number of remaining microscopic cancer cells. The benefit of chemotherapy in synovial sarcoma to overall survival remains unclear, although a recent study has shown that survival of patients with advanced, poorly differentiated disease marginally improves with doxorubicin/ifosfamide treatment.
| |
| *[[Radiotherapy]] to reduce the chance of local recurrence. The benefit of radiotherapy in this disease is less clear than for chemotherapy.
| |
|
| |
| Recent laboratory-based studies have identified a number of potential systemic therapies that may prove more effecacious than conventional chemotherapy and improve survival, however the rarity of this tumor makes clinical trial organization difficult and validation of these experimental therapeutics will likely be long in coming.
| |
|
| |
|
| ==Scans to be undertaken before, during, and after treatment== | | ==Scans to be undertaken before, during, and after treatment== |
Template:DiseaseDisorder infobox
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Scans to be undertaken before, during, and after treatment
Various scanning techniques can be used to further localise and identify this cancer:
During treatment, the patient may have Bone Density Scans, to measure the impact of the chemotherapy on the skeleton.
External links
Template:WikiDoc Sources